Clinical Trial Update: GOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the Elderly [Phase 3]

View source ↗

Summary

This update reports on the Phase 3 GOELAMS SA4 study evaluating the role of fludarabine in treating acute myeloid leukemia in elderly patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Fludarabine (Fludarabine)

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED